Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 2004 Jan 1;377(Pt 1):77–84. doi: 10.1042/BJ20031032

Identification of C-terminal motifs responsible for transmission of inhibition by ATP of mammalian phosphofructokinase, and their contribution to other allosteric effects.

Oscar H Martínez-Costa 1, Carmen Hermida 1, Cristina Sánchez-Martínez 1, Belén Santamaría 1, Juan J Aragón 1
PMCID: PMC1223835  PMID: 12974670

Abstract

Systematic deletions and point mutations in the C-terminal extension of mammalian PFK (phosphofructokinase) led us to identify Leu-767 and Glu-768 of the M-type isoform (PFK-M) as the motifs responsible for the role of this region in inhibition by MgATP. These amino acids are the only residues of the C-terminus that are conserved in all mammalian isoforms, and were found to have a similar function in the C-type isoenzyme. Both residues in PFK-C and Leu-767 in PFK-M were also observed to be critical for inhibition by citrate, which is synergistic with that by MgATP. Binding studies utilizing titration of intrinsic protein fluorescence indicated that the C-terminal part of the enzyme participates in the signal transduction route from the MgATP inhibitory site to the catalytic site, but does not contribute to the binding of this inhibitor, whereas it is essential for the binding of citrate. Mutations of the identified structural motifs did not alter either the action of other allosteric effectors that also interact with MgATP, such as the inhibitor phosphoenolpyruvate and the strong activator fructose 2,6-bisphosphate, or the co-operative effect of fructose 6-phosphate. The latter data provide evidence that activation by fructose 2,6-bisphosphate and fructose 6-phosphate co-operativity are not linked to the same allosteric transition as that mediating inhibition by MgATP.

Full Text

The Full Text of this article is available as a PDF (195.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bock P. E., Frieden C. Phosphofructokinase. II. Role of ligands in pH-dependent structural changes of the rabbit muscle enzyme. J Biol Chem. 1976 Sep 25;251(18):5637–5643. [PubMed] [Google Scholar]
  2. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  3. Chang Simon H., Kemp Robert G. Role of Ser530, Arg292, and His662 in the allosteric behavior of rabbit muscle phosphofructokinase. Biochem Biophys Res Commun. 2002 Jan 18;290(2):670–675. doi: 10.1006/bbrc.2001.6262. [DOI] [PubMed] [Google Scholar]
  4. Colombo G., Tate P. W., Girotti A. W., Kemp R. G. Interaction of inhibitors with muscle phosphofructokinase. J Biol Chem. 1975 Dec 25;250(24):9404–9412. [PubMed] [Google Scholar]
  5. Dunaway G. A., Kasten T. P. Nature of the subunits of the 6-phosphofructo-1-kinase isoenzymes from rat tissues. Biochem J. 1987 Mar 15;242(3):667–671. doi: 10.1042/bj2420667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dunaway G. A., Kasten T. P., Sebo T., Trapp R. Analysis of the phosphofructokinase subunits and isoenzymes in human tissues. Biochem J. 1988 May 1;251(3):677–683. doi: 10.1042/bj2510677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Edelmann Anke, Kirchberger Jürgen, Heinisch Jürgen J., Kopperschläger Gerhard. C-terminal modification of 6-phosphofructo-1-kinase from Saccharomyces cerevisiae and its influence on enzyme structure and activity. Biochem Biophys Res Commun. 2002 Jul 26;295(4):992–999. doi: 10.1016/s0006-291x(02)00773-8. [DOI] [PubMed] [Google Scholar]
  8. Estévez A. M., Heinisch J. J., Aragón J. J. Functional complementation of yeast phosphofructokinase mutants by the non-allosteric enzyme from Dictyostelium discoideum. FEBS Lett. 1995 Oct 23;374(1):100–104. doi: 10.1016/0014-5793(95)01085-s. [DOI] [PubMed] [Google Scholar]
  9. Etiemble J., Simeon J., Buc H. A., Picat C., Boulard M., Boivin P. A liver-type mutation in a case of pronounced erythrocyte phosphofructokinase deficiency without clinical expression. Biochim Biophys Acta. 1983 Sep 13;759(3):236–242. doi: 10.1016/0304-4165(83)90318-5. [DOI] [PubMed] [Google Scholar]
  10. Felíu J. E., Hue L., Hers H. G. Regulation in vitro and in vivo of adenosine 3':5'-monophosphate-dependent inactivation of rat-liver pyruvate kinase type L. Eur J Biochem. 1977 Dec;81(3):609–617. doi: 10.1111/j.1432-1033.1977.tb11988.x. [DOI] [PubMed] [Google Scholar]
  11. Foe L. G., Kemp R. G. Isolation and characterization of phosphofructokinase C from rabbit brain. J Biol Chem. 1985 Jan 25;260(2):726–730. [PubMed] [Google Scholar]
  12. Fothergill-Gilmore L. A. Evolution in glycolysis. Biochem Soc Trans. 1987 Oct;15(5):993–995. doi: 10.1042/bst0150993. [DOI] [PubMed] [Google Scholar]
  13. Frieden C., Gilbert H. R., Bock P. E. Phosphofructokinase. III. Correlation of the regulatory kinetic and molecular properties of the rabbit muscle enzyme. J Biol Chem. 1976 Sep 25;251(18):5644–5647. [PubMed] [Google Scholar]
  14. González-Mateos F., Gómez M. E., García-Salguero L., Sánchez V., Aragón J. J. Inhibition of glycolysis by amino acids in ascites tumor cells. Specificity and mechanism. J Biol Chem. 1993 Apr 15;268(11):7809–7817. [PubMed] [Google Scholar]
  15. Gunasekera D., Kemp R. G. Cloning, sequencing, expression, and purification of the C isozyme of mouse phosphofructokinase. Protein Expr Purif. 1999 Aug;16(3):448–453. doi: 10.1006/prep.1999.1096. [DOI] [PubMed] [Google Scholar]
  16. Kemp R. G., Foe L. G. Allosteric regulatory properties of muscle phosphofructokinase. Mol Cell Biochem. 1983;57(2):147–154. doi: 10.1007/BF00849191. [DOI] [PubMed] [Google Scholar]
  17. Kemp R. G., Fox R. W., Latshaw S. P. Amino acid sequence at the citrate allosteric site of rabbit muscle phosphofructokinase. Biochemistry. 1987 Jun 16;26(12):3443–3446. doi: 10.1021/bi00386a029. [DOI] [PubMed] [Google Scholar]
  18. Kemp Robert G., Gunasekera Dhammika. Evolution of the allosteric ligand sites of mammalian phosphofructo-1-kinase. Biochemistry. 2002 Jul 30;41(30):9426–9430. doi: 10.1021/bi020110d. [DOI] [PubMed] [Google Scholar]
  19. Li Y., Rivera D., Ru W., Gunasekera D., Kemp R. G. Identification of allosteric sites in rabbit phosphofructo-1-kinase. Biochemistry. 1999 Dec 7;38(49):16407–16412. doi: 10.1021/bi991761l. [DOI] [PubMed] [Google Scholar]
  20. Li Y., Valaitis A. P., Latshaw S. P., Kwiatkowska D., Tripathi R. L., Campbell M. C., Kemp R. G. Structure and expression of the cDNA for the C isozyme of phosphofructo-1-kinase from rabbit brain. J Biol Chem. 1994 Feb 25;269(8):5781–5787. [PubMed] [Google Scholar]
  21. MONOD J., WYMAN J., CHANGEUX J. P. ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE MODEL. J Mol Biol. 1965 May;12:88–118. doi: 10.1016/s0022-2836(65)80285-6. [DOI] [PubMed] [Google Scholar]
  22. Martínez-Costa O. H., Estévez A. M., Sánchez V., Aragón J. J. Purification and properties of phosphofructokinase from Dictyostelium discoideum. Eur J Biochem. 1994 Dec 15;226(3):1007–1017. doi: 10.1111/j.1432-1033.1994.01007.x. [DOI] [PubMed] [Google Scholar]
  23. Pettigrew D. W., Frieden C. Binding of regulatory ligands to rabbit muscle phosphofructokinase. A model for nucleotide binding as a function of temperature and pH. J Biol Chem. 1979 Mar 25;254(6):1887–1895. [PubMed] [Google Scholar]
  24. Poorman R. A., Randolph A., Kemp R. G., Heinrikson R. L. Evolution of phosphofructokinase--gene duplication and creation of new effector sites. 1984 May 31-Jun 6Nature. 309(5967):467–469. doi: 10.1038/309467a0. [DOI] [PubMed] [Google Scholar]
  25. Raben N., Exelbert R., Spiegel R., Sherman J. B., Nakajima H., Plotz P., Heinisch J. Functional expression of human mutant phosphofructokinase in yeast: genetic defects in French Canadian and Swiss patients with phosphofructokinase deficiency. Am J Hum Genet. 1995 Jan;56(1):131–141. [PMC free article] [PubMed] [Google Scholar]
  26. Rao G. S., Wariso B. A., Cook P. F., Hofer H. W., Harris B. G. Reaction of Ascaris suum phosphofructokinase with diethylpyrocarbonate. Inactivation and desensitization to allosteric modulation. J Biol Chem. 1987 Oct 15;262(29):14068–14073. [PubMed] [Google Scholar]
  27. Reinhart G. D., Lardy H. A. Rat liver phosphofructokinase: kinetic activity under near-physiological conditions. Biochemistry. 1980 Apr 1;19(7):1477–1484. doi: 10.1021/bi00548a034. [DOI] [PubMed] [Google Scholar]
  28. Santamaria Belen, Estevez Antonio M., Martinez-Costa Oscar H., Aragon Juan J. Creation of an allosteric phosphofructokinase starting with a nonallosteric enzyme. The case of dictyostelium discoideum phosphofructokinase. J Biol Chem. 2001 Nov 7;277(2):1210–1216. doi: 10.1074/jbc.M109480200. [DOI] [PubMed] [Google Scholar]
  29. Schirmer T., Evans P. R. Structural basis of the allosteric behaviour of phosphofructokinase. Nature. 1990 Jan 11;343(6254):140–145. doi: 10.1038/343140a0. [DOI] [PubMed] [Google Scholar]
  30. Setlow B., Mansour T. E. Studies on heart phosphofructokinase. Nature of the enzyme desensitized to allosteric control by photo-oxidation and by acylation with ethoxyformic anhydride. J Biol Chem. 1970 Nov 10;245(21):5524–5533. [PubMed] [Google Scholar]
  31. Sols A. Multimodulation of enzyme activity. Curr Top Cell Regul. 1981;19:77–101. doi: 10.1016/b978-0-12-152819-5.50020-8. [DOI] [PubMed] [Google Scholar]
  32. Sánchez-Martínez C., Aragón J. J. Analysis of phosphofructokinase subunits and isozymes in ascites tumor cells and its original tissue, murine mammary gland. FEBS Lett. 1997 Jun 2;409(1):86–90. doi: 10.1016/s0014-5793(97)00496-1. [DOI] [PubMed] [Google Scholar]
  33. Sánchez-Martínez C., Estévez A. M., Aragón J. J. Phosphofructokinase C isozyme from ascites tumor cells: cloning, expression, and properties. Biochem Biophys Res Commun. 2000 May 19;271(3):635–640. doi: 10.1006/bbrc.2000.2681. [DOI] [PubMed] [Google Scholar]
  34. Uyeda K. Phosphofructokinase. Adv Enzymol Relat Areas Mol Biol. 1979;48:193–244. doi: 10.1002/9780470122938.ch4. [DOI] [PubMed] [Google Scholar]
  35. Valaitis A. P., Foe L. G., Kemp R. G. Desensitization of muscle phosphofructokinase to ATP inhibition by removal of a carboxyl-terminal heptadecapeptide. J Biol Chem. 1987 Apr 15;262(11):5044–5048. [PubMed] [Google Scholar]
  36. Van Schaftingen E. Fructose 2,6-bisphosphate. Adv Enzymol Relat Areas Mol Biol. 1987;59:315–395. doi: 10.1002/9780470123058.ch7. [DOI] [PubMed] [Google Scholar]
  37. Yaney G. C., Schultz V., Cunningham B. A., Dunaway G. A., Corkey B. E., Tornheim K. Phosphofructokinase isozymes in pancreatic islets and clonal beta-cells (INS-1). Diabetes. 1995 Nov;44(11):1285–1289. doi: 10.2337/diab.44.11.1285. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES